0001104659-24-001167.txt : 20240104
0001104659-24-001167.hdr.sgml : 20240104
20240104085629
ACCESSION NUMBER: 0001104659-24-001167
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pelletier Nadege
CENTRAL INDEX KEY: 0001965689
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40367
FILM NUMBER: 24509871
MAIL ADDRESS:
STREET 1: C/O VACCITECH PLC, UNIT 6-10
STREET 2: ZEUS BUILDING RUTHERFORD AVENUE, HARWELL
CITY: DIDCOT
STATE: X0
ZIP: OX11 0DF
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Barinthus Biotherapeutics plc.
CENTRAL INDEX KEY: 0001828185
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UNIT 6-10, ZEUS BUILDING
STREET 2: RUTHERFORD AVENUE, HARWELL
CITY: DIDCOT
STATE: X0
ZIP: OX11 0DF
BUSINESS PHONE: 44 (0) 1865 818808
MAIL ADDRESS:
STREET 1: UNIT 6-10, ZEUS BUILDING
STREET 2: RUTHERFORD AVENUE, HARWELL
CITY: DIDCOT
STATE: X0
ZIP: OX11 0DF
FORMER COMPANY:
FORMER CONFORMED NAME: Vaccitech plc
DATE OF NAME CHANGE: 20210407
FORMER COMPANY:
FORMER CONFORMED NAME: Vaccitech Ltd
DATE OF NAME CHANGE: 20201014
4
1
tm241766-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-02
0
0001828185
Barinthus Biotherapeutics plc.
BRNS
0001965689
Pelletier Nadege
UNIT 6-10, ZEUS BUILDING
RUTHERFORD AVENUE, HARWELL
DIDCOT
X0
OX11 0DF
UNITED KINGDOM
0
1
0
0
Chief Scientific Officer
0
Share Option (Right to Buy)
3.70
2024-01-02
4
A
0
105000
0
A
2034-01-02
Ordinary Shares
105000
105000
D
The shares underlying this option shall vest and become exercisable in three equal annual installments, with the first installment vesting on January 2, 2025.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
/s/ William Enright, Attorney-in-Fact
2024-01-04